Venture capital investors are deepening their bets on single-specialty healthcare, moving beyond oncology and nephrology to areas such as pain management, physiotherapy, and orthotic products.The trend is reflected in several recent funding deals. Bengaluru-based Lumov, which makes orthotic products, is in talks to raise Rs 32 crore in a round led by Peak XV Partners, according to people familiar with the matter. The round will likely include
